Tissue hypoxia leads to an adaptive response regulated via hypoxia inducible factor-1 (consisting of HIF-1α and HIF-1β) [6], and raised HIF-1α levels have been associated with reduced survival, chemotherapy failure, relapse and risk of metastases in breast cancer [5,7,8]. Here, HIF1A is linked to breast cancer.